Identification of a unique intervillous cellular signature in chronic histiocytic intervillositis
Placenta · 2023
DOI: 10.1016/j.placenta.2023.05.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2023. Verfasst von Juliette Krop und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Leiden University Medical Centre, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Placenta Diseases, Abortion, Spontaneous. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
INTRODUCTION: Chronic histiocytic intervillositis (CHI) is a rare histopathological lesion in the placenta characterized by an infiltrate of CD68+ cells in the intervillous space. CHI is associated with adverse pregnancy outcomes such as miscarriage, fetal growth restriction, and (late) intrauterine fetal death. The adverse pregnancy outcomes and a variable recurrence rate of 25-100% underline its clinical relevance. The pathophysiologic mechanism of CHI is unclear, but it appears to be immunologically driven. The aim of this study was to obtain a better understanding of the phenotype of the cellular infiltrate in CHI. METHOD: We used imaging mass cytometry to achieve in-depth visualization of the intervillous maternal immune cells and investigated their spatial orientation in situ in relation to the fetal syncytiotrophoblast. RESULTS: We found three phenotypically distinct CD68+HLA-DR+CD38+ cell clusters that were unique for CHI. Additionally, syncytiotrophoblast cells in the vicinity of these CD68+HLA-DR+CD38+ cells showed decreased expression of the immunosuppressive enzyme CD39. DISCUSSION: The current results provide novel insight into the phenotype of CD68+ cells in CHI. The identification of unique CD68+ cell clusters will allow more detailed analysis of their function and could result in novel therapeutic targets for CHI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Immunology, Leiden University Medical Centre, Leiden, the Netherlands.
- Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.
- Department of Gynecology and Obstetrics, Leiden University Medical Centre, Leiden, the Netherlands.
- Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.
- Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.
- Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Förderung
- Medical Research Council
Zitieren
APA
Krop, J., van der Meeren, L. E., van der Hoorn, M. P., Ijsselsteijn, M. E., Dijkstra, K. L., Kapsenberg, H., van der Keur, C., Cornish, E. F., Nikkels, P. G. J., Koning, F., Claas, F. H. J., Heidt, S., Eikmans, M., & Bos, M. (2023). Identification of a unique intervillous cellular signature in chronic histiocytic intervillositis. Placenta. https://doi.org/10.1016/j.placenta.2023.05.007
Vancouver
Krop J, van der Meeren LE, van der Hoorn MP, Ijsselsteijn ME, Dijkstra KL, Kapsenberg H, et al. Identification of a unique intervillous cellular signature in chronic histiocytic intervillositis. Placenta. 2023. doi:10.1016/j.placenta.2023.05.007
BibTeX
@article{Krop2023,
author = {Krop, Juliette and van der Meeren, Lotte E and van der Hoorn, Marie-Louise P and Ijsselsteijn, Marieke E and Dijkstra, Kyra L and Kapsenberg, H and van der Keur, C and Cornish, Emily F and Nikkels, Peter G J and Koning, Frits and Claas, Frans H J and Heidt, Sebastiaan and Eikmans, Michael and Bos, Manon},
title = {Identification of a unique intervillous cellular signature in chronic histiocytic intervillositis},
journal = {Placenta},
year = {2023},
doi = {10.1016/j.placenta.2023.05.007}
}
EUVIMED